To determine whether there is evidence on the efficacy or effectiveness and safety of the treatment modalities for mesothelioma offered at some centres in the United States. These treatments include genetically targeted fractionated chemotherapy, autologous adoptive immunotherapy, natural killer cell vaccine, intravenous nutrition therapy, oxidative therapy and biodetoxification.